Blueprint Medicines Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	508.82	249.38	204.04	180.08	793.74	Upgrade
Revenue Growth (YoY)	104.04%	22.22%	13.30%	-77.31%	1093.37%	Upgrade
Cost of Revenue	20.16	12.8	26.76	25.74	0.43	Upgrade
Gross Profit	488.66	236.58	177.28	154.35	793.31	Upgrade
Selling, General & Admin	359.27	295.14	237.37	195.29	157.74	Upgrade
Research & Development	341.43	427.72	477.42	601.03	326.86	Upgrade
Operating Expenses	700.71	722.86	714.79	796.33	484.6	Upgrade
Operating Income	-212.04	-486.28	-537.52	-641.98	308.71	Upgrade
Interest Expense	-68.81	-51.61	-17.75	-	-	Upgrade
Interest & Investment Income	18.19	15.35	-	3.75	7.07	Upgrade
Other Non Operating Income (Expenses)	-0.24	-0.95	2	-1.49	-0.37	Upgrade
EBT Excluding Unusual Items	-262.9	-523.48	-553.26	-639.72	315.41	Upgrade
Gain (Loss) on Sale of Investments	23.37	17.47	0.98	-1.36	-0.47	Upgrade
Other Unusual Items	173.68	-	-	-	-	Upgrade
Pretax Income	-65.86	-506.02	-552.28	-641.08	314.94	Upgrade
Income Tax Expense	1.23	0.97	5.24	3	1.06	Upgrade
Net Income	-67.09	-506.98	-557.52	-644.09	313.88	Upgrade
Net Income to Common	-67.09	-506.98	-557.52	-644.09	313.88	Upgrade
Shares Outstanding (Basic)	63	61	60	59	55	Upgrade
Shares Outstanding (Diluted)	63	61	60	59	56	Upgrade
Shares Change (YoY)	3.80%	1.54%	1.92%	4.18%	17.44%	Upgrade
EPS (Basic)	-1.07	-8.37	-9.35	-11.01	5.76	Upgrade
EPS (Diluted)	-1.07	-8.37	-9.35	-11.01	5.59	Upgrade
Free Cash Flow	-197.22	-452.91	-511.2	-301.74	383.88	Upgrade
Free Cash Flow Per Share	-3.14	-7.48	-8.57	-5.16	6.83	Upgrade
Gross Margin	96.04%	94.87%	86.88%	85.71%	99.95%	Upgrade
Operating Margin	-41.67%	-194.99%	-263.44%	-356.50%	38.89%	Upgrade
Profit Margin	-13.18%	-203.30%	-273.24%	-357.67%	39.55%	Upgrade
Free Cash Flow Margin	-38.76%	-181.61%	-250.54%	-167.56%	48.36%	Upgrade
EBITDA	-195.75	-474.61	-525.78	-635.5	315.27	Upgrade
EBITDA Margin	-38.47%	-190.32%	-257.69%	-	39.72%	Upgrade
D&A For EBITDA	16.29	11.67	11.74	6.48	6.56	Upgrade
EBIT	-212.04	-486.28	-537.52	-641.98	308.71	Upgrade
EBIT Margin	-41.67%	-194.99%	-263.44%	-	38.89%	Upgrade
Effective Tax Rate	-	-	-	-	0.34%	Upgrade
Revenue as Reported	508.82	249.38	204.04	180.08	793.74	Upgrade
Advertising Expenses	31.1	16.9	18.1	13.5	9.4	Upgrade

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q